anmelden
SBF 120
6.406,07
PKT
+9,26
PKT
+0,14
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu SBF 120-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.12.21 | LOréal Overweight | JP Morgan Chase & Co. | |
| 08.12.21 | Holcim Outperform | Credit Suisse Group | |
| 08.12.21 | LOréal Outperform | Bernstein Research | |
| 08.12.21 | LOréal Sector Perform | RBC Capital Markets | |
| 08.12.21 | STMicroelectronics Equal-weight | Morgan Stanley | |
| 08.12.21 | Holcim Neutral | JP Morgan Chase & Co. | |
| 08.12.21 | Société Générale (Societe Generale) Overweight | Barclays Capital | |
| 07.12.21 | Schneider Electric Buy | UBS AG | |
| 07.12.21 | Alstom Buy | UBS AG | |
| 07.12.21 | Engie (ex GDF Suez) Overweight | Barclays Capital | |
| 07.12.21 | Schneider Electric Market-Perform | Bernstein Research | |
| 07.12.21 | Holcim Outperform | Credit Suisse Group | |
| 07.12.21 | Air Liquide Overweight | JP Morgan Chase & Co. | |
| 07.12.21 | Sanofi Buy | Jefferies & Company Inc. | |
| 06.12.21 | Renault Overweight | JP Morgan Chase & Co. | |
| 06.12.21 | Engie (ex GDF Suez) Buy | UBS AG | |
| 06.12.21 | SAFRAN Buy | UBS AG | |
| 06.12.21 | Orange Neutral | Credit Suisse Group | |
| 04.12.21 | AXA Outperform | Credit Suisse Group | |
| 03.12.21 | Sanofi Buy | UBS AG | |
| 03.12.21 | Orange Underweight | Barclays Capital | |
| 03.12.21 | SAFRAN Hold | Deutsche Bank AG | |
| 03.12.21 | Sanofi Sell | Deutsche Bank AG | |
| 03.12.21 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 03.12.21 | TotalEnergies Buy | Deutsche Bank AG | |
| 03.12.21 | Schneider Electric Overweight | JP Morgan Chase & Co. | |
| 03.12.21 | Alstom Overweight | JP Morgan Chase & Co. | |
| 03.12.21 | Rexel Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | Airbus Outperform | Credit Suisse Group | |
| 02.12.21 | Sanofi Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | VINCI Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | SAFRAN Overweight | JP Morgan Chase & Co. | |
| 02.12.21 | Sanofi Buy | Kepler Cheuvreux | |
| 02.12.21 | Sanofi Outperform | Credit Suisse Group | |
| 02.12.21 | Sanofi Buy | UBS AG | |
| 02.12.21 | SAFRAN Buy | UBS AG | |
| 02.12.21 | SAFRAN Buy | Goldman Sachs Group Inc. | |
| 02.12.21 | Sanofi Equal Weight | Barclays Capital | |
| 02.12.21 | BNP Paribas Outperform | RBC Capital Markets | |
| 01.12.21 | Sanofi Overweight | JP Morgan Chase & Co. |
